Concepedia

Rachel L. Vimont

RL

6

Publications

464

Citations

6

H-Index

1992

Active since

Affiliations

Roche (United States)(Current)

Institute of Organic Chemistry

Rachel L. Vimont is an author at Roche (United States) specializing in medicine, molecular pharmacology, and pharmacology.

Top concepts

Publications per year

1992–1999

6

Publications

6

RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification.

Anthony Ford, Nicolas F. Arredondo, David R. Blue et al. · Molecular Pharmacology · 1996 · 193 citations

<i>In vitro</i>α<sub>1</sub>‐adrenoceptor pharmacology of Ro 70–0004 and RS‐100329, novel <i>α</i><sub>1A</sub>‐adrenoceptor selective antagonists

T.J. Williams, David R. Blue, Donald V. Daniels et al. · British Journal of Pharmacology · 1999 · 86 citations · Full text

, , +16

Functional evidence equating the pharmacologically‐defined α<sub>1A</sub>‐ and cloned α<sub>1C</sub>‐adrenoceptor: studies in the isolated perfused kidney of rat

David R. Blue, D W Bonhaus, Anthony Ford et al. · British Journal of Pharmacology · 1995 · 58 citations · Full text

α<sub>1L</sub>‐Adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man

M. Shannon Kava, David R. Blue, Rachel L. Vimont et al. · British Journal of Pharmacology · 1998 · 56 citations · Full text

, , +24

Evidence for a noradrenergic innervation to α<sub>1A</sub>‐adrenoceptors in rat kidney

David R. Blue, Rachel L. Vimont, David E. Clarke · British Journal of Pharmacology · 1992 · 36 citations · Full text

, , +19

Rows per page

1–5 of 6